MSK Innovation Hub, the innovation arm of New York City-based Memorial Sloan Kettering Cancer Center, partnered with biotech company NovelStem International to optimize and validate its bioinformatics-based software as a medical device diagnostic platform.
Read the full post on Becker's Hospital Review - Healthcare News
